SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-12-206622
Filing Date
2012-05-03
Accepted
2012-05-03 08:10:32
Documents
4
Period of Report
2012-05-03
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d347144d8k.htm 8-K 15692
2 PRESS RELEASE OF VALEANT PHARMACEUTICALS INTERNATIONAL, INC. DATED MAY 3, 2012. d347144dex991.htm EX-99.1 358122
3 GRAPHIC g347144g58i44.jpg GRAPHIC 6951
4 GRAPHIC g347144g74f31.jpg GRAPHIC 11447
  Complete submission text file 0001193125-12-206622.txt   400798
Mailing Address 4787 LEVY STREET MONTREAL QUEBEC A8 H4R 2P9
Business Address 4787 LEVY STREET MONTREAL QUEBEC A8 H4R 2P9 514-744-6792
Valeant Pharmaceuticals International, Inc. (Filer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14956 | Film No.: 12807440
SIC: 2834 Pharmaceutical Preparations